208 related articles for article (PubMed ID: 25827833)
1. The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.
Dierickx D; Kentos A; Delannoy A
Blood; 2015 May; 125(21):3223-9. PubMed ID: 25827833
[TBL] [Abstract][Full Text] [Related]
2. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment.
Michel M
Presse Med; 2014 Apr; 43(4 Pt 2):e97-e104. PubMed ID: 24680421
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in steroid refractory autoimmune hemolytic anemia.
Gupta N; Sharma S; Seth T; Mishra P; Mahapatra M; Kumar S; Kapoor R; Agarwal N
Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
[TBL] [Abstract][Full Text] [Related]
4. Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.
Santiago-Ríos KJ; Reyes O; Cruz A; Rodríguez-Pabón N; Cáceres W
Bol Asoc Med P R; 2010; 102(2):33-6. PubMed ID: 20939201
[TBL] [Abstract][Full Text] [Related]
5. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
Abadie K; Hege KM
J Med Case Rep; 2014 Jun; 8():175. PubMed ID: 24889270
[TBL] [Abstract][Full Text] [Related]
6. How I treat autoimmune hemolytic anemias in adults.
Lechner K; Jäger U
Blood; 2010 Sep; 116(11):1831-8. PubMed ID: 20548093
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for treatment of autoimmune hemolytic anemia.
Kuzmanovic M; Jurisic V
Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
[TBL] [Abstract][Full Text] [Related]
8. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
[TBL] [Abstract][Full Text] [Related]
9. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
10. A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
Dev M; Mushtaq N; Faisal A
J Pak Med Assoc; 2014 Jun; 64(6):700-2. PubMed ID: 25252495
[TBL] [Abstract][Full Text] [Related]
11. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
13. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Barcellini W; Fattizzo B; Zaninoni A; Radice T; Nichele I; Di Bona E; Lunghi M; Tassinari C; Alfinito F; Ferrari A; Leporace AP; Niscola P; Carpenedo M; Boschetti C; Revelli N; Villa MA; Consonni D; Scaramucci L; De Fabritiis P; Tagariello G; Gaidano G; Rodeghiero F; Cortelezzi A; Zanella A
Blood; 2014 Nov; 124(19):2930-6. PubMed ID: 25232059
[TBL] [Abstract][Full Text] [Related]
14. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Battista ML; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Fanin R; Zanella A
Blood; 2012 Apr; 119(16):3691-7. PubMed ID: 22267606
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
[TBL] [Abstract][Full Text] [Related]
16. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Zanella A
Eur J Haematol; 2013 Dec; 91(6):546-51. PubMed ID: 24033754
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.
Bussone G; Ribeiro E; Dechartres A; Viallard JF; Bonnotte B; Fain O; Godeau B; Michel M
Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460
[TBL] [Abstract][Full Text] [Related]
18. Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.
Mahévas M; Michel M; Vingert B; Moroch J; Boutboul D; Audia S; Cagnard N; Ripa J; Menard C; Tarte K; Mégret J; Le Gallou S; Patin P; Thai L; Galicier L; Bonnotte B; Godeau B; Noizat-Pirenne F; Weill JC; Reynaud CA
J Autoimmun; 2015 Aug; 62():22-30. PubMed ID: 26112660
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune hemolytic anemia].
Berentsen S; Sundic T; Hervig T; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2226-31. PubMed ID: 19898570
[TBL] [Abstract][Full Text] [Related]
20. [The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].
Liu H; Xing LM; Wang HQ; Wu YH; Qu W; Liang Y; Wang GJ; Song J; Wang XM; Guan J; Li LJ; Fu R; Shao ZH
Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):456-9. PubMed ID: 22943757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
